Diversified Healthcare Trust
Diversified Healthcare Trust Q1 FY2026 earnings call
May 5, 2026 · fiscal period ended 2026-03
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2026-05-05
Management highlights
• DHC delivered strong first quarter with normalized FFO of $33.1 million, or 14 cents per share, and adjusted EBITDA RE of $74 million, both ahead of analyst consensus. • Same-property shop portfolio benefited from active asset management, occupancy growth, and rate growth, with margin expansion due to revenue and expense progress. • Focus on deploying capital into high return ROI projects, repositioning underutilized skilled nursing weeks into other living types across 16 communities, six in first phase costing ~$20 million adding ~150 units. • Medical office and life science portfolio had healthy leasing activity. • Sold 13 unencumbered non-core shop communities for $23 million in March and exercised land lease purchase options on two properties for $14.5 million in April.
Segment performance
Consolidated NOI increased 4.7% year-over-year to $75.9 million. Same-property shop portfolio delivered a robust 13.5% increase in NOI year-over-year, reaching $44.3 million, driven by same-property occupancy growth of 110 basis points and average monthly rate growth of 5.9%. Same-property cash basis NOI was $75.9 million, representing an 8.6% increase year-over-year and a 7.8% increase sequentially. Medical office and life science portfolio had same property occupancy increase 60 basis points year over year to 95.3%, generating $25.4 million of NOI, a 3.7% increase over last year, and a 4.8% increase sequentially. Leasing activity was healthy with 169,000 square feet of new and renewal leasing at rents 12% above prior rents with a 9.5-year weighted average lease term.
Guidance
• Reaffirming 2026 ranges: $175 to $185 million of shop NOI, $94 to $98 million of medical office and life science segment NOI, $28 to $30 million of NOI from triple net lease senior living communities and wellness centers, adjusted EBITDA RE of $290 to $305 million, and normalized FFO of 52 to 58 cents per share. • Reaffirming 2026 recurring CapEx guidance of $100 to $115 million, representing ~18% reduction at midpoint. • First quarter results show Shop NOI tracking ahead of initial expectations.
Q&A highlights
Q: Michael Carroll with RBC Capital Markets asked about recurring CapEx expectations, maintenance CapEx run rate, investment opportunities, GNA number.
A: Chris and Anthony responded about recurring CapEx including maintenance and refresh, investment mostly in renovations, GNA volatility tied to share price.
Q: John Masaka with B. Riley asked about one-time items, Alaris property transition, shop occupancy, shop NOI growth, CapEx flow through.
A: Anthony and Chris answered about no major one-time items, smooth Alaris transitions, occupancy affected by seasonality and operator transitions, shop NOI growth expectations, CapEx flow through timelines
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $-0.14 | $-0.15 | +4.5% | — |
| Revenue | $366.5M | $380.2M | -3.6% | — |
Transcript
May 5, 2026Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.